(2021/06/22)
(2021/04/17)
(2021/08/07)
(2020/09/20)
(2016/10/08)
(2016/10/09)
(2016/08/07)
(2012/05/20)
(2012/08/28)
(2010/11/24)
(2010/02/15)
(2008/06/13)
(2010/02/07)
(2008/06/13)
(2008/06/13)
(2008/06/13)
(2008/06/13)
p. 3875 - 3881
(2007/10/03)(2008/06/13)
p. 1277 - 1282
(2007/10/02)4-chloromethyl-5-methyl-1,3-dioxol-2-one
4-bromomethyl-1,3-dioxa-5-methylcyclopentene-2-one
4,5-Dimethyl-1,3-dioxole-2-one
4-formyloxymethyl-5-methyl-1,3-dioxolen-2-one
Azilsartan medoxomil
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
4-((R)-3-(bis(5-methyl-2-oxo-[1,3]dioxol-4-ylmethoxy)phosphoryl)-2-((6-((S)-3-methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl)amino)propionyl)piperazine-1-carboxylic acid butyl ester
(2S,4R)-5-biphenyl-4-yl-2-(hydroxymethyl)-2-methyl-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic acid (5-methyl-2-oxo-[1,3]dioxol-4-yl)methyl ester trifluoroacetate